Schedule 13G ownership disclosure
Cancer Genetics Inc
Security class unavailable · CUSIP: 13739U203
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 242,801
- Percent of class
- 5.9400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001037389-21-000184
- Form type
- SC 13G
- Filer
- Vyant Bio, Inc.
- CIK
- CIK 1349929
- Filed
- Feb 11, 2021
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership